Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 11/20 | 0.43 |
| ▸ | EGFR | P00533 | 3/20 | 0.38 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.38 |
| ▸ | KDR | P35968 | 3/20 | 0.38 |
| ▸ | WDR77 | Q9BQA1 | 3/20 | 0.36 |
| ▸ | UBE2N | P61088 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3405536 | 0.90 | PRMT5 (0.41) | PRMT5EGFRFGFR1KDRUBE2N | |
| SCHEMBL3406384 | 0.89 | PRMT5 (0.39) | PRMT5EGFRFGFR1KDRUBE2N | |
| SCHEMBL3408673 | 0.89 | DRD2 (0.40) | EGFRFGFR1KDRDRD2DRD3 | |
| Hydrochloric Acid SCHEMBL6527164 | 0.88 | DRD2 (0.40) | EGFRFGFR1KDRDRD2DRD3 | |
| SCHEMBL3427255 | 0.87 | EGFR (0.39) | EGFRFGFR1KDRALDH1A1 | |
| SCHEMBL979310 | 0.87 | EGFR (0.39) | EGFRFGFR1KDRDRD2DRD3 | |
| SCHEMBL3406619 | 0.86 | EGFR (0.38) | EGFRFGFR1KDRALDH1A1 | |
| SCHEMBL3401769 | 0.86 | EGFR (0.41) | EGFRFGFR1KDRKDM4EALDH1A1 | |
| SCHEMBL975803 | 0.86 | EGFR (0.39) | PRMT5EGFRFGFR1KDRDRD2 | |
| SCHEMBL3407500 | 0.85 | EGFR (0.37) | PRMT5EGFRFGFR1KDRDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2254862-A2 | AZETIDINE-DERIVED COMPOUNDS, PREPARATION METHOD THEREFOR AND THERAPEUTIC USE OF SAME | Sanofi-Aventis (FR) | 2010-12-01 | — | — | EP | claimed |
| WO-2009118473-A2 | AZETIDINE-DERIVED COMPOUNDS, PREPARATION METHOD THEREFOR AND THERAPEUTIC USE OF SAME | SANOFI-AVENTIS (FR) | 2009-10-01 | — | — | WO | claimed |
| EP-2254862-A2 | AZETIDINE-DERIVED COMPOUNDS, PREPARATION METHOD THEREFOR AND THERAPEUTIC USE OF SAME | Sanofi-Aventis (FR) | 2010-12-01 | — | — | EP | disclosed |
| WO-2009118473-A2 | AZETIDINE-DERIVED COMPOUNDS, PREPARATION METHOD THEREFOR AND THERAPEUTIC USE OF SAME | SANOFI-AVENTIS (FR) | 2009-10-01 | — | — | WO | disclosed |